2825012-76-6
Catalog No.:AA028QVN

2825012-76-6 | 1-[3-(1-methylcyclopropyl)-1,2-oxazol-5-yl]piperazine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
50mg
95%
3 weeks  
$347.00   $243.00
- +
100mg
95%
3 weeks  
$488.00   $342.00
- +
250mg
95%
3 weeks  
$677.00   $474.00
- +
500mg
95%
3 weeks  
$1,033.00   $723.00
- +
1g
95%
3 weeks  
$1,306.00   $914.00
- +
2.5g
95%
3 weeks  
$2,504.00   $1,753.00
- +
5g
95%
3 weeks  
$3,679.00   $2,575.00
- +
10g
95%
3 weeks  
$5,427.00   $3,799.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA028QVN
Chemical Name:
1-[3-(1-methylcyclopropyl)-1,2-oxazol-5-yl]piperazine
CAS Number:
2825012-76-6
Molecular Formula:
C11H17N3O
Molecular Weight:
207.2722
SMILES:
CC1(CC1)c1noc(c1)N1CCNCC1
Properties

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 2825012-76-6
Building Blocks
More >
Tags:2825012-76-6 Molecular Formula|2825012-76-6 MDL|2825012-76-6 SMILES|2825012-76-6 1-[3-(1-methylcyclopropyl)-1,2-oxazol-5-yl]piperazine
Catalog No.: AA028QVN
2825012-76-6
2825012-76-6 | 1-[3-(1-methylcyclopropyl)-1,2-oxazol-5-yl]piperazine
Pack Size: 50mg
Purity: 95%
3 weeks
$347.00 $243.00
Pack Size: 100mg
Purity: 95%
3 weeks
$488.00 $342.00
Pack Size: 250mg
Purity: 95%
3 weeks
$677.00 $474.00
Pack Size: 500mg
Purity: 95%
3 weeks
$1,033.00 $723.00
Pack Size: 1g
Purity: 95%
3 weeks
$1,306.00 $914.00
Pack Size: 2.5g
Purity: 95%
3 weeks
$2,504.00 $1,753.00
Pack Size: 5g
Purity: 95%
3 weeks
$3,679.00 $2,575.00
Pack Size: 10g
Purity: 95%
3 weeks
$5,427.00 $3,799.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA028QVN
Chemical Name: 1-[3-(1-methylcyclopropyl)-1,2-oxazol-5-yl]piperazine
CAS Number: 2825012-76-6
Molecular Formula: C11H17N3O
Molecular Weight: 207.2722
SMILES: CC1(CC1)c1noc(c1)N1CCNCC1
Properties
Building Blocks More >
Submit
© 2017 AA BLOCKS, INC. All rights reserved.